(Q35029530)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Jean-Christophe Bourdon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Philip R Quinlan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Colin A Purdie

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Anne-Catherine Prats

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

David P. Lane

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

3

Alexandra Diot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Marie P Khoury

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Lee Baker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Kenneth Fernandes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Mustapha Aoubala

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Lee B Jordan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Alastair M Thompson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

20 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

published in

Breast Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

R7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1186/bcr2811

20 January 2020

exact match

0 references

cites work

p53 mutation, deprivation and poor prognosis in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

p53 isoform delta113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

Recent advances in p53 research: an interdisciplinary perspective.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

TP53 status and response to chemotherapy in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

p53 in health and disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

Expression of p53 isoforms in squamous cell carcinoma of the head and neck

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

p53 isoforms can regulate p53 transcriptional activity.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2811

DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2811

HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2811

Expression of p53 isoforms in renal cell carcinoma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109573

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

25 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21251329

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21251329

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21251329

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/BCR2811

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21251329%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

21251329

1 reference